Disease Studies

News & Media

See below for details of all PrecisionLife news, events and media activity as well as links to Disease Studies, research, and publications.

PrecisionLife identified as leaders in fight against COVID-19 by Barclays Private Bank

Oxford, UK – PrecisionLife has been identified as a leader in the ongoing fight against COVID-19 by Barclays Private…

Read more

4D Meets AI partnering conference

Oxford, UK – We’ll be at LSci Nation’s 4D Meets AI partnering conference this week where we’ll be leading…

Read more

MedInvest AI, Big Data, Digital Health, and Telemedicine Conference

Oxford, UK – PrecisionLife CEO Dr Steve Gardner will be presenting at MedInvest’s virtual AI, Big Data, and Digital…

Read more

Startup Terrace Global Hack 2020

Oxford, UK – We’re supporting the Startup Terrace Global Hack 2020 – one of Taiwan’s truly international startup events…

Read more

Type-II Diabetes Complications

We built combinatorial risk scores that predict which type of complications a type-II diabetes patient is likely to experience.

Read more


We stratified patients from UK Biobank and via combinatorial analysis identified 345 protein-coding genes strongly associated with disease risk.

Read more


We stratified a schizophrenia patient population to identify disease sub-groups and new targets for treatment responsive and resistant groups.

Read more

ALS Patient Stratification Analysis

We found 33 novel genes that were strongly associated with ALS and have selected 10 targets of significant interest for drug discovery screening.

Read more

Non-T2 (Non-Eosinophilic) Asthma

We revealed clear genetic differences between T2 / non-T2 asthma patients, leading to stratification biomarkers and novel, validated targets for non-T2 asthma.

Read more

Sjögren’s Syndrome

Identification of 299 risk-associated genes that are strongly associated with Sjögren’s syndrome.

Read more

Simon Beaulah joins PrecisionLife as SVP of Healthcare & Head of US Operations

Oxford, UK – PrecisionLife has appointed Simon Beaulah as SVP of Healthcare and Head of US Operations. Simon’s appointment…

Read more

Digital RESI event

Oxford, UK – We’ll be joining startups, technology partners and global investors at digital ‘Redefining Early Stage Investments’ (RESI)…

Read more

PrecisionLife CEO speaks to the 20/15 Visioneers Rock Stars podcast

Oxford, UK – PrecisionLife CEO Dr Steve Gardner was a guest on the thoroughly entertaining 20/15 Visioneers podcast last…

Read more

PrecisionLife present at One Nucleus’ ON Helix event

Oxford, UK – Find out a little more about PrecisionLife at the digital ON Helix 20 event next week…

Read more

Combinatorial analysis of phenotypic and clinical risk factors associated with hospitalized COVID-19 patients

A study using de-identified clinical claims and labs data for US COVID-19 patients. We replicated previous findings around the…

Read more

The COVID-19 PHARMACOME: Rational Selection of Drug Repurposing Candidates from Multimodal Knowledge Harmonization

The SARS-CoV-2 pandemic has challenged researchers at a global scale. The scientific community’s massive response has resulted in a…

Read more

AI Enabled Precision Medicine: Patient Stratification, Drug Repurposing and Combination Therapies

Access to huge patient populations with well-characterized datasets, coupled with novel analytical methods, enables the stratification of complex diseases…

Read more

PrecisionLife featured in Financial Times

Oxford, UK – PrecisionLife has been featured in a Financial Times article following our discovery of 68 genes associated…

Read more

Keep in touch

Please enter your email address if you would like to be kept informed of our work here at PrecisionLife. Note that our Privacy Policy and Terms & Conditions apply.

Contact us

If you have any questions or would like to speak to us in terms of potential collaborations or partnership opportunities, please get in touch using the form below or email info@precisionlife.com and we will get back to you as soon as we can. Note that our Privacy Policy and Terms & Conditions apply.


Unit 8b Bankside
Hanborough Business Park
Long Hanborough, OX29 8LJ


1 Broadway Fl 14
MA 02142-1187


Agern Allé 3


Chmielna 73m
00-801 Warszawa